\-\ Texto\\:\\ \ \(0\)\
\-\ alpha\\-fetoprotein\\ 0\\.6\\ ng\\/dl\\ \\(0\\.0\\-15\\.0\\ ng\\/dl\\)\ \(0\)\
\-\ the\\ patient\\ underwent\\ surgical\\ resection\\ of\\ hepatic\\ segments\\ 5\\ and\\ 6\\ with\\ pathology\\-confirmed\\ hepatocellular\\ carcinoma\\ measuring\\ 6cm\\.\\ \\ no\\ lymph\\-vascular\\ invasion\\.\\ \\ the\\ surgical\\ margins\\ were\\ negative\\ for\\ tumor\\.\\ \\ underlying\\ liver\\ changes\\ consistent\\ with\\ chronic\\ hepatitis\\.\ \(0\)\
\-\ three\\ phase\\ intravenous\\ contrast\\-enhanced\\ ct\\ of\\ the\\ liver\\ demonstrates\\ a\\ subtle\\ hypodense\\ mass\\ in\\ segment\\ 5\\.\\ \\ arterial\\ phase\\ images\\ demonstrate\\ contrast\\ enhancement\\ within\\ the\\ lesion\\ with\\ a\\ serpentine\\ appearance\\.\\ \\ delayed\\ images\\ demonstrate\\ diffuse\\,\\ heterogeneous\\ enhancement\\ of\\ the\\ mass\\.\ \(0\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ 47\\ y\\/o\\ male\\ with\\ colon\\ cancer\\ found\\ to\\ have\\ liver\\ lesion\\ on\\ metestatic\\ screening\\ ct\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatocellular\\:\\ 0\\.1367693923848853\ \(0\)\
\-\ ng\\/dl\\:\\ 0\\.10687029604153842\ \(0\)\
\-\ liver\\:\\ 0\\.0818394864120201\ \(0\)\
\-\ pathology\\-confirmed\\:\\ 0\\.08162517059228239\ \(0\)\
\-\ lymph\\-vascular\\:\\ 0\\.08162517059228239\ \(0\)\
\-\ 0\\.0\\-15\\.0\\:\\ 0\\.07520714114265327\ \(0\)\
\-\ metestatic\\:\\ 0\\.07520714114265327\ \(0\)\
\-\ phase\\:\\ 0\\.07443940515499549\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06727576861155185\ \(0\)\
\-\ 6cm\\:\\ 0\\.06030493824974493\ \(0\)\
\-\ alpha\\-fetoprotein\\:\\ 0\\.05861677568683794\ \(0\)\
\-\ 0\\.6\\:\\ 0\\.054862469130280866\ \(0\)\
\-\ serpentine\\:\\ 0\\.05343514802076921\ \(0\)\
\-\ hepatitis\\:\\ 0\\.04540273535683659\ \(0\)\
\-\ segments\\:\\ 0\\.04452023369198173\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.04435339567806804\ \(0\)\
\-\ enhancement\\:\\ 0\\.04241645863190807\ \(0\)\
\-\ hypodense\\:\\ 0\\.04215591247152947\ \(0\)\
\-\ 47\\:\\ 0\\.0415257878118534\ \(0\)\
\-\ intravenous\\:\\ 0\\.039266735606139955\ \(0\)\
\-\ invasion\\:\\ 0\\.038102204242352604\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03641578039505631\ \(0\)\
\-\ subtle\\:\\ 0\\.03634416014578467\ \(0\)\
\-\ margins\\:\\ 0\\.035935597137368575\ \(0\)\
\-\ arterial\\:\\ 0\\.03463282045122844\ \(0\)\
\-\ segment\\:\\ 0\\.034517797117908464\ \(0\)\
\-\ 5\\.\\:\\ 0\\.03412610841706875\ \(0\)\
\-\ underlying\\:\\ 0\\.03390950768026592\ \(0\)\
\-\ screening\\:\\ 0\\.03375031878637358\ \(0\)\
\-\ surgical\\:\\ 0\\.033263366115767655\ \(0\)\
\-\ hepatic\\:\\ 0\\.03304161436857418\ \(0\)\
\-\ lesion\\:\\ 0\\.032232504185193606\ \(0\)\
\-\ delayed\\:\\ 0\\.032203521706159075\ \(0\)\
\-\ measuring\\:\\ 0\\.03164218261526616\ \(0\)\
\-\ colon\\:\\ 0\\.031073452868725364\ \(0\)\
\-\ images\\:\\ 0\\.030356738739802852\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.029094399599953753\ \(0\)\
\-\ underwent\\:\\ 0\\.02714996329146499\ \(0\)\
\-\ three\\:\\ 0\\.026672446558767687\ \(0\)\
\-\ cancer\\:\\ 0\\.026010789484858937\ \(0\)\
\-\ found\\:\\ 0\\.024935422356038076\ \(0\)\
\-\ resection\\:\\ 0\\.024675144958520544\ \(0\)\
\-\ diffuse\\:\\ 0\\.023953772410882545\ \(0\)\
\-\ 6\\:\\ 0\\.02363074223495254\ \(0\)\
\-\ negative\\:\\ 0\\.02363074223495254\ \(0\)\
\-\ 5\\:\\ 0\\.02314963354114966\ \(0\)\
\-\ changes\\:\\ 0\\.022676370150324632\ \(0\)\
\-\ appearance\\:\\ 0\\.022628764599394828\ \(0\)\
\-\ chronic\\:\\ 0\\.022286941045435184\ \(0\)\
\-\ ct\\:\\ 0\\.022135252840593388\ \(0\)\
\-\ mass\\:\\ 0\\.02200853716569564\ \(0\)\
\-\ y\\/o\\:\\ 0\\.021913231757589264\ \(0\)\
\-\ metastatic\\:\\ 0\\.019917679663111944\ \(0\)\
\-\ consistent\\:\\ 0\\.019400909896585213\ \(0\)\
\-\ tumor\\:\\ 0\\.01844659538528529\ \(0\)\
\-\ were\\:\\ 0\\.017965614228610382\ \(0\)\
\-\ contrast\\:\\ 0\\.017710885988962085\ \(0\)\
\-\ demonstrates\\:\\ 0\\.01728352964493691\ \(0\)\
\-\ have\\:\\ 0\\.017133685910787885\ \(0\)\
\-\ within\\:\\ 0\\.015093809336908163\ \(0\)\
\-\ male\\:\\ 0\\.01430745868414327\ \(0\)\
\-\ disease\\:\\ 0\\.012932755011256519\ \(0\)\
\-\ no\\:\\ 0\\.007967075469479647\ \(0\)\
\-\ patient\\:\\ 0\\.007931406767744332\ \(0\)\
\-\ a\\:\\ 0\\.007344440774418541\ \(0\)\
\-\ for\\:\\ 0\\.006751001376321436\ \(0\)\
\-\ on\\:\\ 0\\.006702694558939149\ \(0\)\
\-\ \\(\\:\\ 0\\.006688534502257967\ \(0\)\
\-\ \\)\\:\\ 0\\.0066068304825306024\ \(0\)\
\-\ the\\:\\ 0\\.006400429847390083\ \(0\)\
\-\ with\\:\\ 0\\.004333488003329249\ \(0\)\
\-\ to\\:\\ 0\\.003954334337435058\ \(0\)\
\-\ in\\:\\ 0\\.0039018262050023603\ \(0\)\
\-\ of\\:\\ 0\\.0032362166888330116\ \(0\)\
\-\ \\,\\:\\ 0\\.0025065746807156238\ \(0\)\
\-\ \\.\\:\\ 0\\.0023008958581613326\ \(0\)\
\-\ and\\:\\ 0\\.0016667500530760967\ \(0\)\
